litlas
ログインアカウント作成

Harry W. Herr

1981–2025 年に発表

別表記
HARRY W. HERR
162
論文数
34,229
被引用数
108
h 指数
161
i10 指数

被引用数

Harry W. Herr の年別被引用数1956 年: 被引用 1 件1982 年: 被引用 1 件1983 年: 被引用 5 件1984 年: 被引用 1 件1985 年: 被引用 15 件1986 年: 被引用 19 件1987 年: 被引用 28 件1988 年: 被引用 23 件1989 年: 被引用 28 件1990 年: 被引用 34 件1991 年: 被引用 31 件1992 年: 被引用 25 件1993 年: 被引用 34 件1994 年: 被引用 36 件1995 年: 被引用 58 件1996 年: 被引用 48 件1997 年: 被引用 83 件1998 年: 被引用 72 件1999 年: 被引用 76 件2000 年: 被引用 108 件2001 年: 被引用 117 件2002 年: 被引用 122 件2003 年: 被引用 180 件2004 年: 被引用 149 件2005 年: 被引用 182 件2006 年: 被引用 188 件2007 年: 被引用 203 件2008 年: 被引用 165 件2009 年: 被引用 214 件2010 年: 被引用 184 件2011 年: 被引用 211 件2012 年: 被引用 226 件2013 年: 被引用 199 件2014 年: 被引用 150 件2015 年: 被引用 125 件2016 年: 被引用 155 件2017 年: 被引用 147 件2018 年: 被引用 170 件2019 年: 被引用 633 件2020 年: 被引用 665 件2021 年: 被引用 472 件2022 年: 被引用 349 件2023 年: 被引用 275 件2024 年: 被引用 484 件2025 年: 被引用 226 件2026 年: 被引用 8 件1957〜1981 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,287 件、この内訳の 27.1%イタリア: 引用元論文 587 件、この内訳の 6.9%中国: 引用元論文 569 件、この内訳の 6.7%ドイツ: 引用元論文 527 件、この内訳の 6.2%カナダ: 引用元論文 444 件、この内訳の 5.3%イギリス: 引用元論文 430 件、この内訳の 5.1%フランス: 引用元論文 353 件、この内訳の 4.2%スペイン: 引用元論文 308 件、この内訳の 3.6%日本: 引用元論文 290 件、この内訳の 3.4%オランダ: 引用元論文 282 件、この内訳の 3.3%オーストリア: 引用元論文 259 件、この内訳の 3.1%スイス: 引用元論文 182 件、この内訳の 2.2%
0%27.1%その他 22.9%

機関

分野

  • Medicine86.7%
  • Biochemistry, Genetics and Molecular Biology7.9%
  • Immunology and Microbiology2%
  • Computer Science0.8%
  • Engineering0.5%
  • Health Professions0.3%
  • その他1.8%

トピック

  • Bladder and Urothelial Cancer Treatments21.8%
  • Urinary and Genital Oncology Studies13.3%
  • Cancer Immunotherapy and Biomarkers2.9%
  • Urinary Tract Infections Management2.8%
  • Renal cell carcinoma treatment2.4%
  • Prostate Cancer Diagnosis and Treatment2.3%
  • その他54.5%

共著者

全論文

検索で開く
  1. NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022

    著者: Thomas W. Flaig, Philippe E. Spiess, Michael Abern, Neeraj Agarwal, Rick Bangs, Stephen A. Boorjian, Mark K. Buyyounouski, Kevin Chan, Sam S. Chang, Terence W. Friedlander, Richard E. Greenberg, Khurshid A. Guru, Harry W. Herr, Jean Hoffman‐Censits, Amar U. Kishan, Shilajit Kundu, Subodh M. Lele, Ronac Mamtani, Vitaly Margulis, Omar Y. Mian, Jeff M. Michalski, Jeffrey S. Montgomery, Lakshminarayanan Nandagopal, Lance C. Pagliaro, Mamta Parikh, Anthony Patterson, Elizabeth R. Plimack, Kamal S. Pohar, Mark A. Preston, Kyle A. Richards, Wade J. Sexton, Arlene O. Siefker‐Radtke, Matthew K. Tollefson, Jonathan D. Tward, Jonathan L. Wright, Mary A. Dwyer, Carly J. Cassara, Lisa A. Gurski - Journal of the National Comprehensive Cancer Network 2022 被引用: 302

  2. Epidemiology and Risk Factors of Urothelial Bladder Cancer

    著者: Maximilian Burger, James W.F. Catto, Guido Dalbagni, H. Barton Grossman, Harry W. Herr, Pierre I. Karakiewicz, Wassim Kassouf, Lambertus A. Kiemeney, Carlo La Vecchia, Shahrokh F. Shariat, Yair Lotan - European Urology 2012 被引用: 2,187

  3. Bladder Cancer, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology

    著者: Thomas W. Flaig, Philippe E. Spiess, Neeraj Agarwal, Rick Bangs, Stephen A. Boorjian, Mark K. Buyyounouski, Sam S. Chang, Tracy M. Downs, Jason A. Efstathiou, Terence W. Friedlander, Richard E. Greenberg, Khurshid A. Guru, Thomas Guzzo, Harry W. Herr, Jean Hoffman‐Censits, Christopher Hoimes, Brant A. Inman, Masahito Jimbo, A. Karim Kader, Subodh M. Lele, Jeff M. Michalski, Jeffrey S. Montgomery, Lakshminarayanan Nandagopal, Lance C. Pagliaro, Sumanta K. Pal, Anthony Patterson, Elizabeth R. Plimack, Kamal S. Pohar, Mark A. Preston, Wade J. Sexton, Arlene O. Siefker‐Radtke, Jonathan D. Tward, Jonathan L. Wright, Lisa A. Gurski, Alyse Johnson-Chilla - Journal of the National Comprehensive Cancer Network 2020 被引用: 628

  4. Bladder Cancer, Version 3.2024

    著者: Thomas W. Flaig, Philippe E. Spiess, Michael Abern, Neeraj Agarwal, Rick Bangs, Mark K. Buyyounouski, Kevin Chan, Sam S. Chang, Paul Chang, Terence W. Friedlander, Richard E. Greenberg, Khurshid A. Guru, Harry W. Herr, Jean Hoffman‐Censits, Hristos Z. Kaimakliotis, Amar U. Kishan, Shilajit Kundu, Subodh M. Lele, Ronac Mamtani, Omar Y. Mian, Jeff M. Michalski, Jeffrey S. Montgomery, Mamta Parikh, Anthony Patterson, Charles C. Peyton, Elizabeth R. Plimack, Mark A. Preston, Kyle A. Richards, Wade J. Sexton, Arlene O. Siefker‐Radtke, Tyler F. Stewart, Debasish Sundi, Matthew K. Tollefson, Jonathan D. Tward, Jonathan L. Wright, Carly J. Cassara, Lisa A. Gurski - Journal of the National Comprehensive Cancer Network 2024 被引用: 236

  5. Defining Early Morbidity of Radical Cystectomy for Patients with Bladder Cancer Using a Standardized Reporting Methodology

    著者: Ahmad Shabsigh, Ruslan Korets, Kinjal Vora, Christine Brooks, Angel M. Cronin, Caroline Savage, Ganesh V. Raj, Bernard H. Bochner, Guido Dalbagni, Harry W. Herr, S. Machele Donat - European Urology 2008 被引用: 1,399

  6. Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma

    著者: Jonathan Coleman, Wesley Yip, Nathan C. Wong, Daniel D. Sjoberg, Bernard H. Bochner, Guido Dalbagni, S. Machele Donat, Harry W. Herr, K. Eugene, Timothy F. Donahue, Eugene J. Pietzak, A. Ari Hakimi, Kwanghee Kim, Hikmat Al‐Ahmadie, H. Alberto Vargas, Ricardo Alvim, Soleen Ghafoor, Nicole Benfante, Anoop Meraney, Steven J. Shichman, Jeffrey M. Kamradt, Suresh Nair, Angelo A. Baccala, Paul Palyca, Bradley W. Lash, Muhammad A. Rizvi, Scott K. Swanson, Antonio F Muina, Andrea B. Apolo, Gopa Iyer, Jonathan E. Rosenberg, Min Yuen Teo, Dean F. Bajorin - Journal of Clinical Oncology 2023 被引用: 105

  7. Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial

    著者: Samuel A. Funt, Michael Lattanzi, Karissa Whiting, Hikmat Al‐Ahmadie, Colleen Quinlan, Min Yuen Teo, Chung‐Han Lee, David H. Aggen, Danielle Elise Zimmerman, Deaglan Joseph McHugh, Arlyn Apollo, Trey Durdin, Hong Truong, Jeffrey M. Kamradt, Maged Khalil, Bradley W. Lash, Irina Ostrovnaya, Asia S. McCoy, Grace Hettich, Ashley Marie Regazzi, Marwah Jihad, Neha Ratna, Abigail Boswell, Kaitlyn Francese, Yuanquan Yang, Edmund Folefac, Harry W. Herr, S. Machele Donat, Eugene J. Pietzak, K. Eugene, Timothy F. Donahue, Alvin C. Goh, William C. Huang, Dean F. Bajorin, Gopa Iyer, Bernard H. Bochner, Arjun Vasant Balar, Amir Mortazavi, Jonathan E. Rosenberg - Journal of Clinical Oncology 2022 被引用: 99

  8. Age‐adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer

    著者: Theresa M. Koppie, Angel M. Serio, Andrew J. Vickers, Kinjal Vora, Guido Dalbagni, S. Machele Donat, Harry W. Herr, Bernard H. Bochner - Cancer 2008 被引用: 357

  9. Health-related Quality of Life for Patients Undergoing Radical Cystectomy: Results of a Large Prospective Cohort

    著者: Matthew Clements, Thomas M. Atkinson, Guido Dalbagni, Yuelin Li, Andrew J. Vickers, Harry W. Herr, S. Machele Donat, Jaspreet S. Sandhu, Daniel Sjöberg, Amy L. Tin, Bruce D. Rapkin, Bernard H. Bochner - European Urology 2021 被引用: 102

  10. Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial

    著者: Bernard H. Bochner, Guido Dalbagni, Daniel D. Sjoberg, Jonathan Silberstein, Gal E. Keren Paz, S. Machele Donat, Jonathan Coleman, Sheila Mathew, Andrew J. Vickers, Geoffrey Schnorr, Michael Feuerstein, Bruce D. Rapkin, Raul O. Parra, Harry W. Herr, Vincent P. Laudone - European Urology 2014 被引用: 597

  11. Long-Term Survival in Metastatic Transitional-Cell Carcinoma and Prognostic Factors Predicting Outcome of Therapy

    著者: Dean F. Bajorin, Paul M. Dodd, Madhu Mazumdar, Melissa Fazzari, John A. McCaffrey, Howard I. Scher, Harry W. Herr, Geralyn Higgins, Mary G. Boyle - Journal of Clinical Oncology 1999 被引用: 729

  12. EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†

    著者: J. Alfred Witjes, Marek Babjuk, Joaquim Bellmunt, H.M. Bruins, Theo M. de Reijke, Maria De Santis, Silke Gillessen, Nicholas D. James, Steven MacLennan, Juan Palou, Tom Powles, María J. Ribal, Shahrokh F. Shariat, Theodorus van der Kwast, Évanguelos Xylinas, Neeraj Agarwal, Tom J.H. Arends, Aristotle Bamias, Alison Birtle, Peter C. Black, Bernard H. Bochner, M. Bolla, Joost L. Boormans, Alberto Bossi, Alberto Briganti, Iris Brummelhuis, Max M. Burger, Daniel Castellano, Richard Cathomas, Arturo Chiti, Ananya Choudhury, Éva Compérat, Simon J. Crabb, Stéphane Culine, Berardino De Bari, Willem de Blok, Pieter De Visschere, Karel Decaestecker, Konstantinos Dimitropoulos, José L. Domínguez-Escrig, Stefano Fanti, Valérie Fonteyne, Mark Frydenberg, Jurgen J. Fütterer, Georgios Gakis, Bogdan Geavlete, Paolo Gontero, Bernhard Grubmüller, S. Hafeez, Donna E. Hansel, Arndt Hartmann, Dickon Hayne, Ann Henry, Virginia Hernández, Harry W. Herr, Ken Herrmann, Peter Hoskin, J. Huguet, Barbara Alicja Jereczek‐Fossa, Rob Jones, Ashish M. Kamat, Vincent Khoo, Anne E. Kiltie, S. Krege, Sylvain Ladoire, Pedro C. Lara, Anna M. Leliveld, Estefanía Linares-Espinós, Vibeke Løgager, Anja Lorch, Yohann Loriot, Richard P. Meijer, Maria Carmen Mir, Marco Moschini, Hugh Mostafid, Arndt‐Christian Müller, Christoph R. Müller, James N’Dow, Andrea Necchi, Y. Neuzillet, Jorg R. Oddens, Jan Oldenburg, Susanne Osanto, Wim J.G. Oyen, Luís Pacheco‐Figueiredo, Helle Pappot, Manish I. Patel, Bradley R. Pieters, Karin Plass, Mesut Remzi, Margitta Retz, Jonathan Richenberg, Michael Rink, Florian Roghmann, Jonathan E. Rosenberg, Morgan Rouprêt, Olivier Rouvière, Carl Salembier, Antti Salminen, Paul Sargos ほか 21 名 - European Urology 2019 被引用: 192

  13. Critical Analysis of Bladder Sparing with Trimodal Therapy in Muscle-invasive Bladder Cancer: A Systematic Review

    著者: Guillaume Ploussard, Siamak Daneshmand, Jason A. Efstathiou, Harry W. Herr, Nicholas D. James, Claus Rödel, Shahrokh F. Shariat, William U. Shipley, Cora N. Sternberg, George N. Thalmann, Wassim Kassouf - European Urology 2014 被引用: 358

  14. History of Bacillus Calmette-Guerin and Bladder Cancer: An Immunotherapy Success Story

    著者: Harry W. Herr, Álvaro Morales - The Journal of Urology 2007 被引用: 355

  15. CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma

    著者: Padmanee Sharma, Yu Shen, Sijin Wen, Sachiko Yamada, Achim A. Jungbluth, Sacha Gnjatic, Dean F. Bajorin, Victor E. Reuter, Harry W. Herr, Lloyd J. Old, Eiichi Sato - National Academy of Sciences, Proceedings of the National Academy of Sciences 2007 被引用: 517

  16. Randomized Trial Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: Oncologic Outcomes

    著者: Bernard H. Bochner, Guido Dalbagni, Karim Marzouk, Daniel D. Sjoberg, Justin Lee, Sheri M. Donat, Jonathan Coleman, Andrew J. Vickers, Harry W. Herr, Vincent P. Laudone - European Urology 2018 被引用: 267

  17. Penile Cancer

    著者: Peter E. Clark, Philippe E. Spiess, Neeraj Agarwal, Matthew C. Biagioli, Mario A. Eisenberger, Richard E. Greenberg, Harry W. Herr, Brant A. Inman, Deborah A. Kuban, Timothy M. Kuzel, Subodh M. Lele, Jeff M. Michalski, Lance C. Pagliaro, Sumanta K. Pal, Anthony Patterson, Elizabeth R. Plimack, Kamal S. Pohar, Michael P. Porter, Jerome P. Richie, Wade J. Sexton, William U. Shipley, Eric J. Small, Donald L. Trump, Geoffrey Wile, Timothy G. Wilson, Mary A. Dwyer, Maria Ho - Journal of the National Comprehensive Cancer Network 2013 被引用: 185

  18. Incidence and Treatment of Complications of Bacillus Calmette-Guerin Intravesical Therapy in Superficial Bladder Cancer

    著者: Donald L. Lamm, A.P.M. van der Meijden, Álvaro Morales, Stanley A. Brosman, William J. Catàlona, Harry W. Herr, Mark S. Soloway, A Steg, F.M.J. Debruyne - The Journal of Urology 1992 被引用: 795

  19. Genomic Differences Between “Primary” and “Secondary” Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy

    著者: Eugene J. Pietzak, Emily C. Zabor, Aditya Bagrodia, Joshua Armenia, Wenhuo Hu, Ahmet Zehir, Samuel A. Funt, François Audenet, David Barron, Noelia Maamouri, Qiang Li, Min Yuen Teo, Maria E. Arcila, Michael F. Berger, Nikolaus Schultz, Guido Dalbagni, Harry W. Herr, Dean F. Bajorin, Jonathan E. Rosenberg, Hikmat Al‐Ahmadie, Bernard H. Bochner, David B. Solit, Gopa Iyer - European Urology 2018 被引用: 152

  20. The Treated Natural History of High Risk Superficial Bladder Cancer: 15-year Outcome

    著者: Michael S. Cookson, Harry W. Herr, Zuo‐Feng Zhang, Scott M. Soloway, Pramod C. Sogani, William R. Fair - The Journal of Urology 1997 被引用: 554

  21. Conservative Management Following Complete Clinical Response to Neoadjuvant Chemotherapy of Muscle Invasive Bladder Cancer: Contemporary Outcomes of a Multi-Institutional Cohort Study

    著者: P Mazza, George W. Moran, Gen Li, Dennis Robins, Justin T. Matulay, Harry W. Herr, G. Joel DeCastro, James M. McKiernan, Christopher B. Anderson - The Journal of Urology 2018 被引用: 78

  22. Outcome of Patients Who Refuse Cystectomy after Receiving Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer

    著者: Harry W. Herr - European Urology 2007 被引用: 95

  23. Urachal Carcinoma

    著者: Anuradha Gopalan, David S. Sharp, Samson W. Fine, Satish K. Tickoo, Harry W. Herr, Victor E. Reuter, Semra Olgac - The American Journal of Surgical Pathology 2009 被引用: 280

  24. Potential Impact of Postoperative Early Complications on the Timing of Adjuvant Chemotherapy in Patients Undergoing Radical Cystectomy: A High-Volume Tertiary Cancer Center Experience

    著者: S. Machele Donat, Ahmad Shabsigh, Caroline Savage, Angel M. Cronin, Bernard H. Bochner, Guido Dalbagni, Harry W. Herr, Matthew I. Milowsky - European Urology 2008 被引用: 260